ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

This study has been completed.
Study NCT00072969.   Last updated on March 3, 2008.   Information provided by National Institutes of Health Clinical Center (CC)
Please refer to this study by its ClinicalTrials.gov identifier: NCT00072969


Locations
United States, Maryland
National Heart, Lung and Blood Institute (NHLBI)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers